Besifloxacin Ophthalmic Suspension, 0.6%: a Novel Topical Fluoroquinolone for Bacterial Conjunctivitis

Overview of attention for article published in Advances in Therapy, June 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,223 followers.

REVIEW by Dr Terrence O'Brien: Besifloxacin Ophthalmic Suspension, 0.6% for Bacterial Conjunctivitis http://t.co/FpIpuWlf

REVIEW: Besifloxacin Ophthalmic Suspension, 0.6%: a Novel Topical Fluoroquinolone for Bacterial Conjunctivitis http://t.co/FpIpuWlf